U.S. flag

An official website of the United States government

NM_018941.4(CLN8):c.411C>G (p.Ile137Met) AND Neuronal ceroid lipofuscinosis 8

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 6, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001832430.1

Allele description [Variation Report for NM_018941.4(CLN8):c.411C>G (p.Ile137Met)]

NM_018941.4(CLN8):c.411C>G (p.Ile137Met)

Gene:
CLN8:CLN8 transmembrane ER and ERGIC protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8p23.3
Genomic location:
Preferred name:
NM_018941.4(CLN8):c.411C>G (p.Ile137Met)
HGVS:
  • NC_000008.11:g.1771465C>G
  • NG_008656.2:g.20688C>G
  • NM_018941.4:c.411C>GMANE SELECT
  • NP_061764.2:p.Ile137Met
  • LRG_691t1:c.411C>G
  • LRG_691:g.20688C>G
  • NC_000008.10:g.1719631C>G
  • NC_000008.10:g.1719631C>G
  • NM_018941.3:c.411C>G
Protein change:
I137M
Links:
dbSNP: rs147224140
NCBI 1000 Genomes Browser:
rs147224140
Molecular consequence:
  • NM_018941.4:c.411C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neuronal ceroid lipofuscinosis 8 (CLN8)
Synonyms:
CLN8-Related Neuronal Ceroid-Lipofuscinosis
Identifiers:
MONDO: MONDO:0010830; MedGen: C1838570; Orphanet: 168491; Orphanet: 228354; Orphanet: 79264; OMIM: 600143

Recent activity

  • Cytochromes b5
    Cytochromes b5
    Cytochromes of the b group that are found bound to cytoplasmic side of ENDOPLASMIC RETICULUM. They serve as electron carrier proteins for a variety of membrane-bound OXYGENASE...<br/>Year introduced: 2004(1990)
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002083174Natera, Inc.
no assertion criteria provided
Uncertain significance
(Apr 6, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002083174.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024